AP640A - A Pyrimidine of formula (1) - Google Patents
A Pyrimidine of formula (1) Download PDFInfo
- Publication number
- AP640A AP640A APAP/P/1996/000857A AP9600857A AP640A AP 640 A AP640 A AP 640A AP 9600857 A AP9600857 A AP 9600857A AP 640 A AP640 A AP 640A
- Authority
- AP
- ARIPO
- Prior art keywords
- salt
- pyrimidine
- enantiomer
- diamino
- dichlorophenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9518027.9A GB9518027D0 (en) | 1995-09-05 | 1995-09-05 | Pharmacologically active compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP9600857A0 AP9600857A0 (en) | 1996-10-31 |
| AP640A true AP640A (en) | 1998-04-14 |
Family
ID=10780172
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1996/000857A AP640A (en) | 1995-09-05 | 1996-09-06 | A Pyrimidine of formula (1) |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US6124308A (sk) |
| EP (1) | EP0879230B1 (sk) |
| JP (1) | JPH11512108A (sk) |
| KR (1) | KR19990044397A (sk) |
| CN (1) | CN1200729A (sk) |
| AP (1) | AP640A (sk) |
| AR (1) | AR004192A1 (sk) |
| AT (1) | ATE203523T1 (sk) |
| AU (1) | AU710091B2 (sk) |
| BG (1) | BG65102B1 (sk) |
| BR (1) | BR9610388A (sk) |
| CA (1) | CA2230362A1 (sk) |
| CO (1) | CO4750651A1 (sk) |
| CZ (1) | CZ65598A3 (sk) |
| DE (1) | DE69614150T2 (sk) |
| EA (1) | EA000695B1 (sk) |
| ES (1) | ES2160834T3 (sk) |
| GB (1) | GB9518027D0 (sk) |
| HR (1) | HRP960399A2 (sk) |
| HU (1) | HUP9901260A3 (sk) |
| ID (1) | ID17274A (sk) |
| IL (1) | IL123414A0 (sk) |
| IS (1) | IS4673A (sk) |
| NO (1) | NO980923L (sk) |
| NZ (1) | NZ318390A (sk) |
| PL (1) | PL325329A1 (sk) |
| SK (1) | SK28598A3 (sk) |
| TR (1) | TR199800386T1 (sk) |
| TW (1) | TW367326B (sk) |
| WO (1) | WO1997009317A2 (sk) |
| YU (1) | YU49796A (sk) |
| ZA (1) | ZA967466B (sk) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR016212A1 (es) * | 1998-04-28 | 2001-06-20 | Astra Ab | Uso de compuestos farmaceuticos que tienen una actividad antagonista de nmda para preparar un medicamento para el tratamiento del sindrome de intestino irritable (ibs), y composiciones farmaceuticas |
| US6420354B1 (en) | 1998-06-08 | 2002-07-16 | Advanced Medicine, Inc. | Sodium channel drugs and uses |
| AU4672699A (en) * | 1998-06-08 | 1999-12-30 | Theravance, Inc. | Novel sodium channel drugs and uses |
| GB9907965D0 (en) * | 1999-04-09 | 1999-06-02 | Glaxo Group Ltd | Medical use |
| US6479498B1 (en) | 1999-06-04 | 2002-11-12 | Theravance, Inc. | Sodium channel drugs and uses |
| CA2416819C (en) * | 2000-07-21 | 2011-03-22 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| CA2439468A1 (en) * | 2001-02-27 | 2002-09-06 | Teva Pharmaceutical Industries Ltd. | New crystal forms of lamotrigine and processes for their preparations |
| IL163666A0 (en) | 2002-02-22 | 2005-12-18 | New River Pharmaceuticals Inc | Active agent delivery systems and methods for protecting and administering active agents |
| CA2483103A1 (en) * | 2002-04-23 | 2003-11-06 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical composition containing lamotrigine particles of defined morphology |
| JP2006515326A (ja) * | 2003-01-30 | 2006-05-25 | ダイノジェン ファーマシューティカルズ， インコーポレイテッド | 胃腸管障害を処置するためのナトリウムチャネルモジュレーターの使用 |
| GB0603087D0 (en) * | 2006-02-15 | 2006-03-29 | Glaxo Group Ltd | Novel use |
| US8093268B2 (en) * | 2007-01-24 | 2012-01-10 | Glaxo Group Limited | Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-) |
| GB201111712D0 (en) | 2011-07-08 | 2011-08-24 | Gosforth Ct Holdings Pty Ltd | Pharmaceutical compositions |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0372934A2 (en) * | 1988-12-07 | 1990-06-13 | The Wellcome Foundation Limited | Pharmacologically active CNS compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU182086B (en) * | 1979-06-01 | 1983-12-28 | Wellcome Found | Process for preparing new 1,2,4-triazine derivatives |
-
1995
- 1995-09-05 GB GBGB9518027.9A patent/GB9518027D0/en active Pending
-
1996
- 1996-09-03 JP JP9510854A patent/JPH11512108A/ja not_active Ceased
- 1996-09-03 DE DE69614150T patent/DE69614150T2/de not_active Expired - Lifetime
- 1996-09-03 AU AU69865/96A patent/AU710091B2/en not_active Ceased
- 1996-09-03 CN CN96197823A patent/CN1200729A/zh active Pending
- 1996-09-03 ES ES96931006T patent/ES2160834T3/es not_active Expired - Lifetime
- 1996-09-03 US US09/029,162 patent/US6124308A/en not_active Expired - Fee Related
- 1996-09-03 CZ CZ98655A patent/CZ65598A3/cs unknown
- 1996-09-03 BR BR9610388A patent/BR9610388A/pt not_active Application Discontinuation
- 1996-09-03 HR HR9518027.9A patent/HRP960399A2/hr not_active Application Discontinuation
- 1996-09-03 CA CA002230362A patent/CA2230362A1/en not_active Abandoned
- 1996-09-03 CO CO96046885A patent/CO4750651A1/es unknown
- 1996-09-03 EA EA199800189A patent/EA000695B1/ru not_active IP Right Cessation
- 1996-09-03 KR KR1019980701641A patent/KR19990044397A/ko not_active Application Discontinuation
- 1996-09-03 ID IDP962513A patent/ID17274A/id unknown
- 1996-09-03 WO PCT/EP1996/003856 patent/WO1997009317A2/en not_active Application Discontinuation
- 1996-09-03 NZ NZ318390A patent/NZ318390A/xx unknown
- 1996-09-03 EP EP96931006A patent/EP0879230B1/en not_active Expired - Lifetime
- 1996-09-03 PL PL96325329A patent/PL325329A1/xx unknown
- 1996-09-03 TR TR1998/00386T patent/TR199800386T1/xx unknown
- 1996-09-03 SK SK285-98A patent/SK28598A3/sk unknown
- 1996-09-03 AT AT96931006T patent/ATE203523T1/de not_active IP Right Cessation
- 1996-09-03 IL IL12341496A patent/IL123414A0/xx unknown
- 1996-09-03 HU HU9901260A patent/HUP9901260A3/hu unknown
- 1996-09-04 ZA ZA9607466A patent/ZA967466B/xx unknown
- 1996-09-04 AR ARP960104220A patent/AR004192A1/es unknown
- 1996-09-04 YU YU49796A patent/YU49796A/sh unknown
- 1996-09-05 TW TW085110879A patent/TW367326B/zh active
- 1996-09-06 AP APAP/P/1996/000857A patent/AP640A/en active
-
1998
- 1998-02-23 IS IS4673A patent/IS4673A/is unknown
- 1998-03-04 NO NO980923A patent/NO980923L/no not_active Application Discontinuation
- 1998-03-23 BG BG102342A patent/BG65102B1/bg unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0372934A2 (en) * | 1988-12-07 | 1990-06-13 | The Wellcome Foundation Limited | Pharmacologically active CNS compounds |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP640A (en) | A Pyrimidine of formula (1) | |
| US7705148B2 (en) | Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile | |
| US8802678B2 (en) | Carbonylated (aza) cyclohexanes as dopamine D3 receptor ligands | |
| US7888345B2 (en) | Benzaepinones as sodium channel blockers | |
| JPH11503167A (ja) | タキキニン受容体拮抗物質としての２−アシルアミノプロパンアミド類 | |
| US20100144715A1 (en) | Substituted Benzodiazepinones, Benzoxazepinones and Benzothiazepinones as Sodium Channel Blockers | |
| WO2006115244A1 (ja) | ４－ブロモイソキノリン誘導体及びこれを含有する医薬 | |
| US20080058535A1 (en) | Methods and compositions for production, formulation and use of 1 aryl-3-azabicyclo[3.1.0]hexanes | |
| US20080214542A1 (en) | Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands | |
| WO1992017440A1 (fr) | Compose tricyclique | |
| US6465461B1 (en) | Triazine compounds for treatment of CNS disorders | |
| KR20010042904A (ko) | 광학 활성 테트라하이드로벤즈인돌 유도체 | |
| KR20020082470A (ko) | 심리학적 장애의 치료를 위한 게피론의 생활성 대사물질의용도 | |
| US20120088809A1 (en) | 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds | |
| EP2277882A1 (fr) | Composés pipéridiniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
| JP3999861B2 (ja) | 新規ピリダジン誘導体及びこれを有効成分とする医薬 | |
| MXPA98001680A (en) | Derivative of phenyl pyrimidine optically active as analges agent | |
| JPH11180979A (ja) | 環状アミン誘導体 | |
| US20230002404A1 (en) | Heterobicyclic carboxamides and uses thereof | |
| JP2004525985A (ja) | Ｎ−（２，３−ジメチル−５，６，７，８−テトラヒドロフロ［２，３−ｂ］キノリン−４−イル）−２−（２−オキソプロリジン−１−イル）アセトアミドの結晶多形 | |
| JPH07173161A (ja) | ピリドピリミジン誘導体、その製造方法および用途 | |
| JP2007091732A (ja) | チオモルホリン化合物及びその製法 | |
| MXPA00006223A (en) | Triazine compounds for treatment of cns disorders | |
| KR20070017019A (ko) | 아고멜라틴의 결정질 형태 ⅲ, 이의 제조 방법 및 이를함유하는 약제 조성물 |